These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3226337)

  • 1. Gynecologic consequences of long-term, unopposed estrogen replacement therapy.
    Ettinger B; Golditch IM; Friedman G
    Maturitas; 1988 Dec; 10(4):271-82. PubMed ID: 3226337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies concerning the safety of estrogen replacement therapy.
    Whitehead MI; Fraser D
    Am J Obstet Gynecol; 1987 May; 156(5):1313-22. PubMed ID: 3555093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
    McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
    Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative analytic methods for case-control studies of estrogens and endometrial cancer.
    Horwitz RI; Feinstein AR
    N Engl J Med; 1978 Nov; 299(20):1089-94. PubMed ID: 703785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials.
    Mirkin S; Pinkerton JV; Kagan R; Thompson JR; Pan K; Pickar JH; Komm BS; Archer DF
    J Womens Health (Larchmt); 2016 May; 25(5):431-42. PubMed ID: 27058301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of postmenopausal bleeding to prevent endometrial cancer.
    Gambrell RD; Castaneda TA; Ricci CA
    Maturitas; 1978 Sep; 1(2):99-106. PubMed ID: 755962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecologic complications of cyclic estrogen progestin therapy.
    Ettinger B; Selby JV; Citron JT; Ettinger VM; Zhang D
    Maturitas; 1993 Nov; 17(3):197-204. PubMed ID: 8133794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroids and cancer.
    Gambrell RD
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens, progestogens and endometrial cancer.
    Gambrell RD
    J Reprod Med; 1977 Jun; 18(6):301-6. PubMed ID: 196079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical considerations in the management of the menopause: the endometrium.
    Whitehead MI; McQueen J; Minardi J; Campbell S
    Postgrad Med J; 1978; 54 Suppl 2():69-73. PubMed ID: 740583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens.
    Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA
    J Am Geriatr Soc; 1979 Sep; 27(9):389-94. PubMed ID: 469150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens and endometrial carcinoma.
    Gray LA; Christopherson WM; Hoover RN
    Obstet Gynecol; 1977 Apr; 49(4):385-9. PubMed ID: 193072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens.
    Campbell S; McQueen J; Minardi J; Whitehead MI
    Postgrad Med J; 1978; 54 Suppl 2():59-64. PubMed ID: 740582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen use in postmenopausal women--costs, risks, and benefits.
    Weinstein MC
    N Engl J Med; 1980 Aug; 303(6):308-16. PubMed ID: 6770270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer and the use of estrogens.
    Gambrell RD
    Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is bleeding a predictor of endometrial hyperplasia in postmenopausal women receiving hormone replacement therapy? Menopause Study Group (United States, Italy, Netherlands, Switzerland, Belgium, Germany, and Finland.
    Pickar JH; Archer DF
    Am J Obstet Gynecol; 1997 Nov; 177(5):1178-83. PubMed ID: 9396916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.